Detalhe da pesquisa
1.
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.
Immunity;
51(4): 766-779.e17, 2019 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31495665
2.
Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.
Immunity;
54(2): 388, 2021 Feb 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33567264
3.
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction.
Proteomics;
18(12): e1700259, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29314742
4.
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations.
Cell Rep Methods;
1(5): 100084, 2021 09 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35474673
5.
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
Genome Med;
12(1): 70, 2020 08 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32791978
6.
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.
Nat Biotechnol;
29(7): 635-43, 2011 Jun 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21685905
7.
Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.
Mol Cancer Res;
8(6): 896-906, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20501647
8.
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.
Nat Biotechnol;
27(7): 633-41, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19561596